Endothelin-1 antagonism and nitric oxide augmentation prevents cyclosporine-induced vasomotor impairment

Our study suggests potential therapeutic strategies to prevent endothelial dysfunction as combined therapy with ET-1 antagonism and NO augmentation completely abrogated CyA-induced vascular injury.